Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03104491
Title Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Leland Metheny
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA

Facility Status City State Zip Country Details
The University of Kansas Cancer Center RECRUITING Westwood Kansas 66205 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
University of Nebraska Medical Center RECRUITING Omaha Nebraska 68106 United States Details
Memorial Sloan Kettering Cancer Center ACTIVE_NOT_RECRUITING New York New York 10065 United States Details
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center RECRUITING Cleveland Ohio 44106-5065 United States Details
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center ACTIVE_NOT_RECRUITING Cleveland Ohio 44195 United States Details
The James Cancer Hospital and Solove Research Institute RECRUITING Columbus Ohio 43210 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field